Studies have shown that intestinal BCRP dysfunction in obesity results from reduced Janus kinase 3 (JAK3)-mediated phosphorylation, which is essential for BCRP localization and activity, leading to increased drug retention and dysregulated gut-liver communication [131]. This evidence concerns the gene ABCG2 and obesity disorder.